Sivelestat sodium
Sponsors
Sichuan Provincial People's Hospital, Southeast University, China, Nanfang Hospital, Southern Medical University, First Affiliated Hospital Xi'an Jiaotong University, The First Hospital of Jilin University
Conditions
ARDSARDS Due to Disease Caused by SARS Co-V-2Acute Ischemic StrokeAcute Lung Injury/Acute Respiratory Distress Syndrome (ARDS)Acute Respiratory Distress SyndromeAortic DissectionInflammatory ResponseLarge Vessel Occlusion
Phase 3
Phase 4
Unknown Phase
Effect of Early Treatment With Sivelestat Sodium in ARDS Patients
NCT05020210
Start: 2021-09-30End: 2023-08-31Target: 560Updated: 2022-12-21
Improvement of Pulmonary Insufficiency After Aortic Dissection With Sivelestat Sodium
NCT05343338
Start: 2022-04-20End: 2024-12-31Target: 168Updated: 2022-04-25
Neutrophil Elastase Inhibitor in Treatment of ARDS Patients With Mechanical Ventilation Caused by Sepsis
NCT05672472
Start: 2023-01-10End: 2025-02-10Target: 100Updated: 2023-01-05
Clinical Effects of Sivelestat Sodium on Improving ARDS in Patients With COVID-19
CompletedNCT06218862
Start: 2022-12-01End: 2023-05-31Updated: 2024-01-23
Efficacy and Safety of Sivelestat Sodium and Dexamethasone in the Treatment of ARDS
RecruitingNCT06387823
Start: 2024-04-15End: 2025-09-01Target: 300Updated: 2024-06-04
Sivelestat Sodium as an Adjunct to Endovascular Thrombectomy for Acute Anterior Circulation Large-Vessel Occlusion
Not yet recruitingNCT07552610
Start: 2026-06-01End: 2029-05-01Target: 868Updated: 2026-04-27